Comments of DPR's TAC document for Methidathion

OEHHA has provided a number of comments and concerns on the risk characterization methodology and conclusions of the TAC documents for Methidathion. These comments and our recommendations, as well as suggested clarifications, additions and corrections, are contained in this report.